Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Q32 Bio Q4 2024 GAAP EPS $(1.16) Beats $(1.51) Estimate, Cash And Cash Equivalents Of $78M As Of December 31, 2024 Expected To Provide Financial Runway Into 2H 2026

Author: Benzinga Newsdesk | March 11, 2025 07:00am

Q32 Bio (NASDAQ:QTTB) reported quarterly losses of $(1.16) per share which beat the analyst consensus estimate of $(1.51) by 23.18 percent.

Posted In: QTTB